868 related articles for article (PubMed ID: 17223020)
1. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
[TBL] [Abstract][Full Text] [Related]
2. Integrity of liposomes in presence of various formulation excipients, when dispersed in aqueous media and in hydrogels.
Mourtas S; Duraj S; Fotopoulou S; Antimisiaris SG
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):270-6. PubMed ID: 17928204
[TBL] [Abstract][Full Text] [Related]
3. 5-Fluorouracil in topical liposome gels for anticancer treatment--formulation and evaluation.
Glavas-Dodov M; Fredro-Kumbaradzi E; Goracinova K; Calis S; Simonoska M; Hincal AA
Acta Pharm; 2003 Dec; 53(4):241-50. PubMed ID: 14769231
[TBL] [Abstract][Full Text] [Related]
4. Stability evaluation of temoporfin-loaded liposomal gels for topical application.
Dragicevic-Curic N; Winter S; Krajisnik D; Stupar M; Milic J; Graefe S; Fahr A
J Liposome Res; 2010 Mar; 20(1):38-48. PubMed ID: 19558347
[TBL] [Abstract][Full Text] [Related]
5. Calcein release behavior from liposomal bilayer; influence of physicochemical/mechanical/structural properties of lipids.
Maherani B; Arab-Tehrany E; Kheirolomoom A; Geny D; Linder M
Biochimie; 2013 Nov; 95(11):2018-33. PubMed ID: 23871914
[TBL] [Abstract][Full Text] [Related]
6. Temoporfin-loaded liposomal gels: viscoelastic properties and in vitro skin penetration.
Dragicevic-Curic N; Winter S; Stupar M; Milic J; Krajisnik D; Gitter B; Fahr A
Int J Pharm; 2009 May; 373(1-2):77-84. PubMed ID: 19429291
[TBL] [Abstract][Full Text] [Related]
7. Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
Lim HJ; Masin D; McIntosh NL; Madden TD; Bally MB
J Pharmacol Exp Ther; 2000 Jan; 292(1):337-45. PubMed ID: 10604968
[TBL] [Abstract][Full Text] [Related]
8. Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability.
Mohammed AR; Weston N; Coombes AG; Fitzgerald M; Perrie Y
Int J Pharm; 2004 Nov; 285(1-2):23-34. PubMed ID: 15488676
[TBL] [Abstract][Full Text] [Related]
9. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
10. Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
Lim HJ; Masin D; Madden TD; Bally MB
J Pharmacol Exp Ther; 1997 Apr; 281(1):566-73. PubMed ID: 9103545
[TBL] [Abstract][Full Text] [Related]
11. Effect of preparation technique on the properties of liposomes encapsulating ketoprofen-cyclodextrin complexes aimed for transdermal delivery.
Maestrelli F; González-Rodríguez ML; Rabasco AM; Mura P
Int J Pharm; 2006 Apr; 312(1-2):53-60. PubMed ID: 16469460
[TBL] [Abstract][Full Text] [Related]
12. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
13. Modulated release from liposomes entrapped in chitosan/gelatin hydrogels.
Ciobanu BC; Cadinoiu AN; Popa M; Desbrières J; Peptu CA
Mater Sci Eng C Mater Biol Appl; 2014 Oct; 43():383-91. PubMed ID: 25175227
[TBL] [Abstract][Full Text] [Related]
14. Liposomal gel with chloramphenicol: characterisation and in vitro release.
Pavelić Z; Skalko-Basnet N; Jalsenjak I
Acta Pharm; 2004 Dec; 54(4):319-30. PubMed ID: 15634615
[TBL] [Abstract][Full Text] [Related]
15. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
Stevens PJ; Lee RJ
Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
[TBL] [Abstract][Full Text] [Related]
16. Complex hydrogel systems composed of polymers, liposomes, and cyclodextrins: implications of composition on rheological properties and aging.
Mourtas S; Aggelopoulos CA; Klepetsanis P; Tsakiroglou CD; Antimisiaris SG
Langmuir; 2009 Aug; 25(15):8480-8. PubMed ID: 19496549
[TBL] [Abstract][Full Text] [Related]
17. Folate-PEG coated cationic modified chitosan--cholesterol liposomes for tumor-targeted drug delivery.
Wang H; Zhao P; Liang X; Gong X; Song T; Niu R; Chang J
Biomaterials; 2010 May; 31(14):4129-38. PubMed ID: 20163853
[TBL] [Abstract][Full Text] [Related]
18. Delivery of cisplatin from Pluronic co-polymer systems: liposome inclusion and alginate coupling.
Fang JY; Hsu SH; Leu YL; Hu JW
J Biomater Sci Polym Ed; 2009; 20(7-8):1031-47. PubMed ID: 19454167
[TBL] [Abstract][Full Text] [Related]
19. Effect of vehicle on topical liposomal drug delivery: petrolatum bases.
Foldvari M
J Microencapsul; 1996; 13(5):589-600. PubMed ID: 8864995
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes.
Schroeder A; Kost J; Barenholz Y
Chem Phys Lipids; 2009 Nov; 162(1-2):1-16. PubMed ID: 19703435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
